RxDoctor Payments Data

Christina Lankhorst, MD

Nephrology · Sioux Falls, SDNPI 1134336340

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.1% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Among nephrology clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,270in general payments, 2019–2025

Across 64 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$226
  • Travere Therapeutics, Inc.$103
  • Novartis$100
  • Mallinckrodt Hospital Products Inc.$86
  • Fresenius USA Marketing, Inc.$71
  • Amgen$66
  • plus $617 from 19 others

What the payments were for

  • Food & beverage$1,19594%
  • Education$756%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,270 in reported general payments places this provider in the 95th percentile of 26 nephrology providers in South Dakota.

See all nephrology providers in South Dakota

Medicare billing

Part B allowed, 2024
$205,202
Medicare patients
688
Services billed
1,888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sevelamer Carbonate28$3,177
Calcium Acetate38$2,762
Potassium Citrate ErPotassium Citrate24$1,663
Calcitriol69$1,127
Potassium Chloride26$767
Allopurinol54$578
Amlodipine Besylate59$558
Furosemide71$422
Hydralazine Hcl23$381
Tamsulosin Hcl33$354
Torsemide16$330
Losartan Potassium45$324
Doxazosin Mesylate20$301
Prednisone26$209
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$203

Paid to pharmacies, not to this prescriber.

Other nephrology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →